In cisplatin-resistant non-small cell lung cancer (NSCLC), exosomal miR-425-3p down-regulates AKT1 inducing autophagy and leading to therapeutic failure both in early and advanced stages (Yuwen et al., 2019). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.